Table 1 Baseline characteristics
| Â | Number of patients (%) |
|---|---|
Histology | Â |
Non-small cell lung cancer | 56 (88%) |
Other | 6 (9%) |
No pathology | 2 (3%) |
Dose schedule | Â |
6 Gy × 5 fractions | 2 (3%) |
8 Gy × 5 fractions | 7 (11%) |
9 Gy × 5 fractions | 1 (1.5%) |
10 Gy × 5 fractions | 10 (16%) |
10.5 Gy × 5 fractions | 7 (11%) |
12 Gy × 4 fractions | 17 (27%) |
18 Gy* × 3 fractions | 19 (29%) |
Other | 1 (1.5%) |
Tumor size | Â |
≤ 3 cm | 36 (56%) |
>3Â cm | 28 (44%) |
SBRT indication | Â |
Refused surgery | 7 (11%) |
Medically inoperable | 47 (73%) |
Surgically incurable | 10 (16%) |
Location | Â |
Central | 23 (36% |
Peripheral | 41 (64%) |